Implementation of Dapagliflozin in Patients With Chronic Kidney Disease Trial Overview (Q&A)
Prof David Wheeler
Professor, Kidney Medicine at University College London, UK Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust